These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 11450846)
1. Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line. Fujiwara H; Emi M; Nagai H; Ohgaki K; Imoto I; Akimoto M; Ogawa O; Habuchi T J Hum Genet; 2001; 46(7):372-7. PubMed ID: 11450846 [TBL] [Abstract][Full Text] [Related]
2. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456 [TBL] [Abstract][Full Text] [Related]
3. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Habuchi T; Luscombe M; Elder PA; Knowles MA Genomics; 1998 Mar; 48(3):277-88. PubMed ID: 9545632 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines. Williams SV; Sibley KD; Davies AM; Nishiyama H; Hornigold N; Coulter J; Kennedy WJ; Skilleter A; Habuchi T; Knowles MA Genes Chromosomes Cancer; 2002 May; 34(1):86-96. PubMed ID: 11921286 [TBL] [Abstract][Full Text] [Related]
5. A sequence-ready 840-kb PAC contig spanning the candidate tumor suppressor locus DBC1 on human chromosome 9q32-q33. Nishiyama H; Hornigold N; Davies AM; Knowles MA Genomics; 1999 Aug; 59(3):335-8. PubMed ID: 10444335 [TBL] [Abstract][Full Text] [Related]
6. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608 [TBL] [Abstract][Full Text] [Related]
7. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858 [TBL] [Abstract][Full Text] [Related]
8. A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Habuchi T; Yoshida O; Knowles MA Hum Mol Genet; 1997 Jun; 6(6):913-9. PubMed ID: 9175739 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb. Bell SM; Zuo J; Myers RM; Knowles MA Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728 [TBL] [Abstract][Full Text] [Related]
10. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB; Amare Kadam PS Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [TBL] [Abstract][Full Text] [Related]
11. Defining a common region of deletion at 13q21 in human cancers. Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524 [TBL] [Abstract][Full Text] [Related]
12. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p). Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184 [TBL] [Abstract][Full Text] [Related]
13. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331 [TBL] [Abstract][Full Text] [Related]
14. Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA. Devlin J; Keen AJ; Knowles MA Oncogene; 1994 Sep; 9(9):2757-60. PubMed ID: 8058343 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder. Van Tilborg AA; Hekman AC; Vissers KJ; van der Kwast TH; Zwarthoff EC Int J Cancer; 1998 Jan; 75(1):9-14. PubMed ID: 9426683 [TBL] [Abstract][Full Text] [Related]
17. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029 [TBL] [Abstract][Full Text] [Related]
19. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. Stadler WM; Steinberg G; Yang X; Hagos F; Turner C; Olopade OI Clin Cancer Res; 2001 Jun; 7(6):1676-82. PubMed ID: 11410506 [TBL] [Abstract][Full Text] [Related]
20. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cairns P; Tokino K; Eby Y; Sidransky D Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]